For research use only. Not for therapeutic Use.
Febuxostat Impurity 6 (Cat No.: I014935) is a known byproduct in the synthesis of febuxostat, a xanthine oxidase inhibitor used to manage hyperuricemia in gout patients. Characterization of such impurities is essential for ensuring the safety and efficacy of pharmaceutical products. Analytical standards for Febuxostat Impurity 6 are available for method development and validation in quality control processes.
| CAS Number | 1271738-74-9 |
| Molecular Formula | C₁₈H₂₂N₂O₄S |
| Purity | ≥95% |
| Target | Drug Metabolite |
| IUPAC Name | ethyl 2-[3-[(E)-hydroxyiminomethyl]-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate |
| InChI | 1S/C18H22N2O4S/c1-5-23-18(21)16-12(4)20-17(25-16)13-6-7-15(24-10-11(2)3)14(8-13)9-19-22/h6-9,11,22H,5,10H2,1-4H3/b19-9+ |
| InChIKey | XISYIGZAZNITQC-DJKKODMXSA-N |
| SMILES | CCOC(=O)C1=C(N=C(S1)C2=CC(=C(C=C2)OCC(C)C)/C=N/O)C |
| Reference | [1]. Leonid Metsger, et al. Processes for preparing febuxostat. WO2011031409A1. |
